LENZ Therapeutics, Inc. (LENZ)

Corporate Overview

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, proudly based in San Diego. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia.

Our Leadership

Latest Financial Results

FY 2023

Fiscal Year Ended Dec 31, 2023

10-K PDF

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Latest News

Apr 3, 2024 • 7:00 AM EDT

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

View Press Release View All News

Recent Event

Apr 3, 2024 8:00 am EDT

CLARITY Phase 3 Topline Results Conference Call

View Event View All Events

Email Alerts

Get the latest news and reports delivered right to your inbox.

IR Contacts

Corporate

LENZ Therapeutics, Inc.
445 Marine View Ave.
Suite 320
Del Mar, CA 92014
T: 858-925-7000
contact@lenz-tx.com

Investor Relations

Stern Investor Relations, Inc.
Julie Seidel
T: 212-698-8684
Julie.seidel@sternir.com

Transfer Agent

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449